InFlectis BioScience: Clinical Trials

1 trial sponsored by InFlectis BioScience, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow InFlectis BioScience: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol)
IFB-088 50mg/day, Placebo, Riluzole 100mg/day - Amyotrophic Lateral Sclerosis, ALS
Phase 2CompletedInFlectis BioScience512022-12-022025-10-10

Conditions studied

Amyotrophic Lateral Sclerosis (1)  ·  Motor Neuron Disease (1)  ·  Neurodegenerative Diseases (1)

Interventions

Riluzole (1)

Countries

France (1)  ·  Italy (1)

Top investigators

Giuseppe Lauria, Pr (1)  ·  Shahram Attarian, Pr (1)